The tech sector is built on bright minds developing new solutions to create economic or social impact. This fast-paced industry has high stakes, which require people to meet even higher expectations. Many individuals within the sector — especially startup founders — have small teams (meaning each person serves in multiple roles), work long hours, second jobs or are still in school and constantly worry about “making it.”
At the DMZ, we see that many entrepreneurs are still not talking openly about their mental well-being. And these challenges aren’t special to our organization. Mental health concerns in tech entrepreneurship are often referred to as “founder’s blues.” Between 2011 and 2017, founder’s blues has contributed to a number of high-profile suicides in the startup world, including Aaron Swartz, co-founder of Reddit.
Researchers from the University of California found that 72% of entrepreneurs surveyed self-reported mental health concerns. And about 49% disclosed they deal with ADD, ADHD, bipolar disorder, addiction, depression or anxiety. These figures were described as “significantly higher” than non-entrepreneurs.
Watching as a video game ensnares their child, many a parent has grumbled about “digital heroin,” likening the flashing images to one of the world’s most addictive substances.
Now, they may have backup: The World Health Organization is set to announce “gaming disorder” as a new mental health condition to be included in the 11th edition of its International Classification of Diseases, set to release Monday.
“I’m not creating a precedent,” said Dr. Vladimir Poznyak, a member of WHO’s Department of Mental Health and Substance Abuse, which proposed the new diagnosis to WHO’s decision-making body, the World Health Assembly. Instead, he said, WHO has followed “the trends, the developments, which have taken place in populations and in the professional field.”
A new study by researchers at Duke University reports an abnormality in visual regions of the brain that is associated with a person’s general risk for mental illness. The findings, published in Biological Psychiatry, indicate a signature abnormality shared between common forms of mental illness, which could help clinicians assess a patient’s general risk for developing a mental illness. The signature abnormality was present in participants involved in the study who already had a higher risk of mental illness. This was characterized by a reduced efficiency between visual areas and brain networks important for integrating sensory information and suppressing distracting information.
Researchers have long thought that some aspects of the biology of the risk for psychiatric disorders were specific to particular disorders, and by studying specific groups of patients, may have mistaken general risk factors as specific risk factors. Newer research suggests that a person’s risk for developing mental illness is not specific to one form of disorder, but is instead shared across many different disorders. “In other words, there may be a single risk factor that predicts whether an individual develops any form of psychiatric disorder, be it depression, post-traumatic stress disorder, addiction, or even schizophrenia,” said first author Maxwell Elliott, a doctoral student in the laboratory of Ahmad Hariri, PhD.
Brief psychological interventions delivered by lay counsellors in primary care were effective and cost-effective for patients with depression and harmful drinking in India, according to two studies in PLOS Medicine by Vikram Patel of Harvard Medical School, USA, and colleagues from the London School of Hygiene & Tropical Medicine, London, UK and Sangath, India. The authors have previously reported the effectiveness of the two interventions, Healthy Activity Programme (HAP) and Counselling for Alcohol Problems (CAP), at 3 months; however, the longer-term benefits of the interventions were previously unknown.
In the first trial, 493 adult primary health care attendees with moderately severe or severe depression were randomly assigned to either the HAP treatment plus enhanced usual care (EUC), or enhanced usual care (EUC) alone. The researchers found that HAP participants maintained the benefits they showed at the end of treatment through the 12-month period, with significantly lower symptom severity scores (adjusted mean difference in BDI-II: ?4.45) and higher rates of remission (PHQ-9 score < 5: 63% versus 48%) than participants who received EUC alone.
The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana University.
The risk of substance use problems during periods of medication use was 35 percent lower in men and 31 percent lower in women in the study. The results, based upon nearly 3 million people with ADHD in the United States, are reported in the American Journal of Psychiatry.
“This study contributes to growing evidence that ADHD medication is linked to lower risk for many types of harmful behavior, including substance abuse,” said Patrick D. Quinn, a postdoctoral researcher in the IU Bloomington College of Arts and Sciences’ Department of Psychological and Brain Sciences, who led the study. “The results also highlight the importance of careful diagnosis and compliance with treatment.”
A Case Western Reserve University School of Medicine researcher has found that addiction treatment results improved when teens in a residential program stopped smoking. The findings are published in a new study in the November issue of the Journal of Substance Abuse Treatment. They hold important implications for success in treating addiction since up to three out of four people with such disorders are smokers, a significantly higher proportion than the overall national smoking rate of one out of every four Americans.
The study found that teens who stopped smoking benefited from lower cravings for alcohol and drugs, and did as well as their peers who smoked in terms of treatment duration, 12-step participation, and global functioning (a numeric scale used by mental health professionals to rate how well clients respond to various psychological and social situations and difficulties). In contrast, young people in the study who smoked were discharged with significantly higher cravings for alcohol and drugs, which has been shown to increase the risk of relapse.
There are many reports of drug use leading to mental health problems, and we all know of someone having a few too many drinks to cope with a bad day. Many people who are diagnosed with a mental health disorder indulge in drugs, and vice versa. As severity of both increase, problems arise and they become more difficult to treat. But why substance involvement and psychiatric disorders often co-occur is not well understood.
In addition to environmental factors, such as stress and social relationships, a person’s genetic make-up can also contribute to their vulnerability to drug use and misuse as well as mental health problems. So could genetic risk for mental illness be linked to a person’s liability to use drugs?
This question has been addressed in a new study, published in the open-access journal Frontiers in Genetics.
Young and single men are at risk of being addicted to video games. The addiction indicates an escape from ADHD and psychiatric disorder.
“Video game addiction is more prevalent among younger men, and among those not being in a current relationship, than others,” says, Cecilie Schou Andreassen, doctor of psychology and clinical psychologist specialist at Department of Psychosocial Science, University of Bergen (UiB).
Schou Andreassen has carried out a study with more than 20 000 participants who answered questions related to videogame addiction. The study is published in the journal Psychology of Addictive Behaviors, of the American Psychological Association.
Escape from psychiatric disorders
The study showed that video game addiction appears to be associated with attention deficit/hyperactivity disorder, obsessive-compulsive disorder, and depression.